The Academy of Molecular Imaging (AMI) has signed on with the American College of Radiology's (ACR) Image Metrix division to provide data and image infrastructure for a new study.
The research will compare the effectiveness of conventional planar technetium-99m methylene diphosphonate (Tc-99m MDP) bone imaging with fluorine-18 sodium fluoride (F-18 NaF) PET/CT at detecting bony metastases in patients with breast, prostate, and non-small cell lung cancers, according to ACR Image Metrix in Philadelphia.
The protocol was developed in conjunction with the U.S. Food and Drug Administration (FDA) and calls for data collection on more than 500 patients at 13 sites in the U.S.
Related Reading
AMI's PET/CT bone imaging trial enrolls patients, May 12, 2009
ACR Image Metrix chosen as AMI's CRO, January 29, 2009
ACR Image Metrix reaches milestone, September 30, 2008
ACR aims to become Medicare accrediting body, July 31, 2008
ACR to accredit VA radiation oncology sites, July 17, 2008
AMI, ACRIN partner on PET registry development, February 7, 2005
Copyright © 2009 AuntMinnie.com
